Respiratory syncytial virus vaccine (Pierre Fabre)
呼吸道合胞病毒疫苗（皮尔法伯）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRespiratory syncytial virus vaccine (Pierre Fabre)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A